InRange Diabetes

🚨 Big news for the Type 1 Diabetes community in Australia! 🇦🇺
Today, Tzield (teplizumab) has been approved by the TGA for people aged 8+ with Stage 2 Type 1 Diabetes.

Why is this such a big deal? Because for the first time, we are talking about delaying progression to clinical type 1 diabetes — before someone is needing insulin therapy and living with the day-to-day burden of T1D.

On average, this treatment may provide around 2 extra years before progression to stage 3 T1D. Two years without insulin therapy, alarms, carb counting, hypos, ketones, or the emotional and financial load that can come with T1D.

As someone living with type 1 diabetes myself, and working as a Nurse Practitioner supporting people with diabetes every day, this feels genuinely exciting. It also highlights something important:

Type 1 diabetes doesn’t suddenly appear.
It often starts years earlier, silently, through autoimmune changes that can now be detected.

And here’s the part many people don’t realise: most people diagnosed with T1D have no family history. Which means early detection and broader screening conversations matter more than ever.

This feels like the beginning of a really important shift in how we think about type 1 diabetes — from reacting to diagnosis, to identifying and intervening earlier 💙
What are your thoughts on screening and early detection for T1D?

Fantastic type 1 diabetes (T1D) news in Australia this morning: Tzield has been approved by the Therapeutic Goods Administration (TGA) for use in people aged 8+ years who are in stage 2 T1D!

Here’s why it’s so exciting:

🧪 Tzield (teplizumab) can delay the progression of T1D from stage 2 (before people start showing T1D symptoms) to stage 3 (when symptoms of T1D begin and people start needing insulin therapy).

☺️ On average, Tzield means an extra 2 years of life without insulin. That's an extra 2 years without the physical, emotional, financial and mental burdens of T1D.

💉 This is the first new drug approved for T1D in over 100 years, since the discovery of insulin!

🩸 People can only be found in the early stages of T1D through screening. That’s why Breakthrough T1D has been funding early detection and screening initiatives in Australia for many years and is a global leader in the field.

💰 Breakthrough T1D has funded the development of teplizumab for almost 4 decades, from the early discovery research to the landmark clinical trials that proved it could delay T1D progression.

🔓 Next up, Breakthrough T1D will be advocating for the therapy to be listed on the Pharmaceutical Benefits Scheme (PBS), so it can become subsidised and available for all people with stage 2 T1D who want to access it.

We'll share more about Tzield and what this means in the days to come – you can also click the link in the comments to learn more about this exciting news!

If you caught Episode 88 of Think Like a Pancreas — The Podcast, you already know that jet lag and sleep disruption can throw your blood sugar off when you travel.

But here's the thing--poor sleep affects your glucose at home too.
✔️Pump alarms.
✔️CGM alerts.
✔️Middle-of-the-night lows.

If you live with diabetes, you know the cycle➡️ poor sleep disrupts your blood sugar ➡️poor blood sugar disrupts your sleep.

Can you actually do anything about it?

Yes!

Gary Scheiner and Kathryn Alvarez share how in their Type 1 University lecture: Sleep Your Way to Better Diabetes Management.

For just $25 USD, they walk you through the physiology of sleep, why insufficient sleep hits people with diabetes differently, how glucose and sleep affect each other, and — most importantly — practical strategies to improve both your sleep quality and your nighttime glucose management.

Better sleep.
Better numbers.
Better mornings.

Click on the QR code or comment SLEEP for the T1 University link.

The ACNP Flagship award, Nurse Practitioner of the Year, is sponsored by HESTA. This prestigious award is presented to an ACNP Nurse Practitioner who has demonstrated outstanding qualities in the areas of clinical work, mentoring and leadership.

This is an opportunity for the incredible work of Nurse Practitioners to be showcased at a National level by peers, colleagues and community members.

The award is valued at up to $2,000 to support an individual’s Nurse Practitioner development. The successful nominee will receive 1 registration to attend ACNP National Conference in September and 1 year of ACNP membership.

ACNP welcomes applications from Nurse Practitioners nationwide who are members.

❗Closing 30 June. Check the guidelines and nominate today! https://www.acnp.org.au/hesta-nurse-practitioner-of-the-year---

Can GLP-1 medications be beneficial for people with type 1 diabetes? While not FDA-approved for T1D, their off-label use is increasing — especially among those with insulin resistance or a higher BMI.

We asked diabetes expert Diana Isaacs about the benefits, risks, and real-world use of GLP-1s.

Read the full breakdown →

https://t1dx.co/4ncAPJO

Medicare is failing the bush: Nursing and midwifery bodies demand urgent action, and reform can’t wait.

Together, twelve national organisations, including the Australian College of Nurse Practitioners (ACNP), are calling out a system that is no longer meeting the needs of rural, regional and remote Australians.

Current Medicare and pharmaceutical policy settings are delaying diagnosis, fragmenting care, and driving avoidable hospital admissions in the bush. These are not administrative issues; they are real-world barriers to timely, essential care.

Through our joint letter and ACNP submission to the Senate Standing Committees on Rural and Regional Affairs and Transport, we have highlighted how existing restrictions are compromising access and placing increasing strain on already fragile models of care.

Nurse practitioners, nurses and midwives are ready to deliver solutions but need policy settings that enable, rather than constrain, equitable access to care.

Reform is not optional. It is essential for safety, sustainability, and health equity.

Read the joint letter, joint press release, submission and other media at https://tinyurl.com/Advocacy-Find-Out-More